Gates Biomanufacturing Facility Announces Strategic Manufacturing Agreement with Cell Therapy Pioneer, Nkarta
- Tuesday, October 5, 2021, 7:05
- Finance
- Add a comment
AURORA, Colo., Oct. 5, 2021 /PRNewswire/ — The Gates Biomanufacturing Facility (GBF) today announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells. As part of this collaboration, GBF will continue to manufacture…
About the Author
adminasapcorp has written 41532 stories on this site.